Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

NCT02446652 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped Due to a lack of sufficient resources, the opening was not carried out.

Conditions

Cervical Cancer

Interventions

DRUG: Hydralazine/Magnesium
DRUG: Placebo
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

National Institute of Cancerología

Collaborators

[object Object]